By Leah Douglas WASHINGTON, May 18 (Reuters) - Dozens of state anti-vaccine bills backed by "Make America Healthy Again" ...
GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk: London, UK Tuesday, May 19, 2026, 12:00 Hrs [IST] GSK plc announced tha ...
Jesse Goodman, former director of CBER and former FDA chief scientist, calls for five critical changes to restore trust in ...